Search research articles
Contact Us
Filters
Showing results (261-270 of 312) with videos related to
Page
of 32
Sort By:
Journal of Lipid Research
|
August 23, 2012
Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying
Gene P Ables, Kryscilla Jian Zhang Yang, Silke Vogel, et al.
Diabetes Care
|
December 4, 2013
Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
Peter E Linz, Laura C Lovato, Robert P Byington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2000
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
A Fard, C H Tuck, J A Donis, et al.
Journal of Lipid Research
|
January 6, 2011
DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle
Li Liu, Shuiqing Yu, Raffay S Khan, et al.
The Journal of Nutrition
|
June 4, 2020
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials
Penny M Kris-Etherton, Paul W Stewart, Henry N Ginsberg, et al.
Cell Metabolism
|
February 6, 2008
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis
Sudha B Biddinger, Antonio Hernandez-Ono, Christian Rask-Madsen, et al.
The Journal of Clinical Investigation
|
April 3, 2012
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice
Ding Ai, Juan M Baez, Hongfeng Jiang, et al.
Science Translational Medicine
|
January 29, 2016
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
Gissette Reyes-Soffer, Byoung Moon, Antonio Hernandez-Ono, et al.
Circulation
|
December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
John B Buse, Henry N Ginsberg, George L Bakris, et al.
The New England Journal of Medicine
|
March 4, 2011
Long-term effects of intensive glucose lowering on cardiovascular outcomes
, Hertzel C Gerstein, Michael E Miller, et al.
Page
of 32
Search research articles
Search
Showing results (261-270 of 312) with videos related to
Sort By:
Page
of 32
Journal of Lipid Research
|
August 23, 2012
Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying
Gene P Ables, Kryscilla Jian Zhang Yang, Silke Vogel, et al.
Diabetes Care
|
December 4, 2013
Paradoxical reduction in HDL-C with fenofibrate and thiazolidinedione therapy in type 2 diabetes: the ACCORD Lipid Trial
Peter E Linz, Laura C Lovato, Robert P Byington, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2000
Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes
A Fard, C H Tuck, J A Donis, et al.
Journal of Lipid Research
|
January 6, 2011
DGAT1 deficiency decreases PPAR expression and does not lead to lipotoxicity in cardiac and skeletal muscle
Li Liu, Shuiqing Yu, Raffay S Khan, et al.
The Journal of Nutrition
|
June 4, 2020
The Type and Amount of Dietary Fat Affect Plasma Factor VIIc, Fibrinogen, and PAI-1 in Healthy Individuals and Individuals at High Cardiovascular Disease Risk: 2 Randomized Controlled Trials
Penny M Kris-Etherton, Paul W Stewart, Henry N Ginsberg, et al.
Cell Metabolism
|
February 6, 2008
Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis
Sudha B Biddinger, Antonio Hernandez-Ono, Christian Rask-Madsen, et al.
The Journal of Clinical Investigation
|
April 3, 2012
Activation of ER stress and mTORC1 suppresses hepatic sortilin-1 levels in obese mice
Ding Ai, Juan M Baez, Hongfeng Jiang, et al.
Science Translational Medicine
|
January 29, 2016
Complex effects of inhibiting hepatic apolipoprotein B100 synthesis in humans
Gissette Reyes-Soffer, Byoung Moon, Antonio Hernandez-Ono, et al.
Circulation
|
December 29, 2006
Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association
John B Buse, Henry N Ginsberg, George L Bakris, et al.
The New England Journal of Medicine
|
March 4, 2011
Long-term effects of intensive glucose lowering on cardiovascular outcomes
, Hertzel C Gerstein, Michael E Miller, et al.
Page
of 32